Company Search:
Advanced Search
Sponsored Links
China Biologic Products Inc Company Snapshot
China Biologic Products Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares China Biologic Products Inc with three other companies in this sector in China: Beijing Tiantan Biologic. (2016 sales of 2.10 billion Chinese Renmimbi [US$310.40 million] of which 99% was Biological products industry), Tonghua Dongbao Medicines Company Limited (2.03 billion Chinese Renmimbi [US$300.69 million] of which 96% was Pharmaceutical), and Hualan Biological Engineering Inc (1.93 billion Chinese Renmimbi [US$286.51 million] of which 94% was Blood Product).

Sales Analysis. During the year ended December of 2016, sales at China Biologic Products Inc were 2.27 billion Chinese Renmimbi (US$336.24 million). This is an increase of 21.8% versus 2015, when the company's sales were 1.86 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at China Biologic Products Inc (and since 2011, sales have increased a total of 130%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
China Biologic Products Inc
  Stock Performance Chart for China Biologic Products Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 695.65
(Figures in Chinese Renmimbi)
1 Week 0.8%   13 Weeks -9.0%  
4 Weeks -11.4%   52 Weeks -5.9%  
China Biologic Products Inc Key Data:
  Ticker: CBPO Country: China
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 2,269,923,012
(Year Ending Jan 2017).
Employees: 1,799
  Currency: Chinese Renmimbi Market Cap: 18,922,642,192
  Fiscal Yr Ends: December Shares Outstanding: 27,201,477
  Share Type: Gu Closely Held Shares: 3,835,509
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.